Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 3D-34 refers to a pseudogene of the immunoglobulin kappa variable (IGKV) gene family, specifically the 3D-34 variant. Immunoglobulin kappa variable genes are responsible for encoding the variable domain of the kappa light chain of immunoglobulins (antibodies), which play a fundamental role in antigen recognition as part of the adaptive immune response. However, IGKV3D-34 is designated as a pseudogene, meaning it is a non-functional DNA segment that resembles a gene but typically does not encode a functional protein product, nor does it serve as a direct therapeutic target[1][3]. Key points: - The IGKV gene family includes many functional genes and pseudogenes, located in clusters within the immunoglobulin kappa locus[3]. - "3D-34" identifies a specific pseudogene within the IGKV3 subgroup (distal cluster), but there is no evidence that IGKV3D-34 encodes a functional protein. - Pseudogenes such as IGKV3D-34 are not typically considered direct therapeutic targets, nor do they interact with drugs or have documented roles as clinical biomarkers. - Information for related functioning genes such as IGKV3-11 indicates that active immunoglobulin kappa variable genes participate in antigen binding and immune response, but the pseudogene IGKV3D-34 itself does not contribute directly due to its lack of protein expression[4]. Summary: IGKV3D-34 is a nonfunctional immunoglobulin gene pseudogene, not a therapeutic target, enzyme, receptor, or transporter, and it is designated "incorrect" for most therapeutic target applications due to its pseudogene status[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin kappa variable 3D-34 (IGKV3D-34).